CD33 and acute myeloid leukemia: Thus, it is interesting to speculate that other factors that are associated with CD33 expression levels on primary AML cells impact AMG 330-induced cytotoxicity, thereby masking a relationship between target antigen expression and BiTE antibody construct efficacy.